Gałka, N.; Tomaka, E.; Tomaszewska, J.; Pańczyszyn-Trzewik, P.; Sowa-Kućma, M.
Gepirone for Major Depressive Disorder: From Pharmacokinetics to Clinical Evidence: A Narrative Review. Int. J. Mol. Sci. 2025, 26, 9805.
https://doi.org/10.3390/ijms26199805
AMA Style
Gałka N, Tomaka E, Tomaszewska J, Pańczyszyn-Trzewik P, Sowa-Kućma M.
Gepirone for Major Depressive Disorder: From Pharmacokinetics to Clinical Evidence: A Narrative Review. International Journal of Molecular Sciences. 2025; 26(19):9805.
https://doi.org/10.3390/ijms26199805
Chicago/Turabian Style
Gałka, Natalia, Emilia Tomaka, Julia Tomaszewska, Patrycja Pańczyszyn-Trzewik, and Magdalena Sowa-Kućma.
2025. "Gepirone for Major Depressive Disorder: From Pharmacokinetics to Clinical Evidence: A Narrative Review" International Journal of Molecular Sciences 26, no. 19: 9805.
https://doi.org/10.3390/ijms26199805
APA Style
Gałka, N., Tomaka, E., Tomaszewska, J., Pańczyszyn-Trzewik, P., & Sowa-Kućma, M.
(2025). Gepirone for Major Depressive Disorder: From Pharmacokinetics to Clinical Evidence: A Narrative Review. International Journal of Molecular Sciences, 26(19), 9805.
https://doi.org/10.3390/ijms26199805